3 terminated, 2 completed. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 3, Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow tetomilast: new trials by email Literature Review of tetomilast trials Research Report on tetomilast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease Placebo, OPC-6535 - Crohn's Disease | Phase 2 / Phase 3 | Completed | Otsuka Pharmaceutical Co., Ltd. | 191 | 2009-10-01 | 2021-04-06 |
| To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) Patients tetomilast (OPC-6535), placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Otsuka Pharmaceutical Co., Ltd. | 771 | 2009-03-01 | 2021-04-30 |
| Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema tetomilast, placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Terminated | Otsuka Pharmaceutical Development & Commercialization, Inc. | 84 | 2009-03-01 | 2017-04-17 |
| A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease OPC-6535(Tetomilast) - Crohn Disease | Phase 2 | Terminated | Otsuka Pharmaceutical Co., Ltd. | 29 | 2006-05-01 | 2021-02-15 |
| A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis OPC-6535(Tetomilast) - Colitis, Ulcerative | Phase 2 | Terminated | Otsuka Pharmaceutical Co., Ltd. | 43 | 2006-05-01 | 2021-04-30 |
Crohn Disease (2) · Pulmonary Disease, Chronic Obstructive (2) · Colitis, Ulcerative (1) · Emphysema (1)
Otsuka Pharmaceutical Co., Ltd. (4) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1)
Japan (4) · South Korea (2) · China (1) · United States (1)
Katsuhisa Saito (3)